Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study.
Paller AS, Flohr C, Eichenfield LF, Irvine AD, Weisman J, Soung J, Pinto Correia A, Natalie CR, Rodriguez Capriles C, Pierce E, Reifeis S, Gontijo Lima R, Armengol Tubau C, Laquer V, Weidinger S. Paller AS, et al. Among authors: flohr c. Dermatol Ther (Heidelb). 2023 Jul;13(7):1517-1534. doi: 10.1007/s13555-023-00942-y. Epub 2023 Jun 15. Dermatol Ther (Heidelb). 2023. PMID: 37318750 Free PMC article.
Biomarkers for atopic dermatitis: a systematic review and meta-analysis.
Thijs J, Krastev T, Weidinger S, Buckens CF, de Bruin-Weller M, Bruijnzeel-Koomen C, Flohr C, Hijnen D. Thijs J, et al. Among authors: flohr c. Curr Opin Allergy Clin Immunol. 2015 Oct;15(5):453-60. doi: 10.1097/ACI.0000000000000198. Curr Opin Allergy Clin Immunol. 2015. PMID: 26226355 Review.
Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review.
Barbarot S, Rogers NK, Abuabara K, Aubert H, Chalmers J, Flohr C, Hanifin J, Naldi L, Margolis DJ, Paul C, Ridd MJ, Schuttelaar MA, Simpson E, Tauber M, Volke A, Weidinger S, Wilkes SR, Wollenberg A, Thomas KS. Barbarot S, et al. Among authors: flohr c. J Am Acad Dermatol. 2016 Nov;75(5):1038-1044. doi: 10.1016/j.jaad.2016.05.043. Epub 2016 Aug 10. J Am Acad Dermatol. 2016. PMID: 27522613 Review.
Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
Totri CR, Eichenfield LF, Logan K, Proudfoot L, Schmitt J, Lara-Corrales I, Sugarman J, Tom W, Siegfried E, Cordoro K, Paller AS, Flohr C. Totri CR, et al. Among authors: flohr c. J Am Acad Dermatol. 2017 Feb;76(2):281-285. doi: 10.1016/j.jaad.2016.09.021. Epub 2016 Nov 14. J Am Acad Dermatol. 2017. PMID: 27855965
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.
Gerbens LA, Boyce AE, Wall D, Barbarot S, de Booij RJ, Deleuran M, Middelkamp-Hup MA, Roberts A, Vestergaard C, Weidinger S, Apfelbacher CJ, Irvine AD, Schmitt J, Williamson PR, Spuls PI, Flohr C. Gerbens LA, et al. Among authors: flohr c. Trials. 2017 Feb 27;18(1):87. doi: 10.1186/s13063-016-1765-7. Trials. 2017. PMID: 28241851 Free PMC article.
Looking beyond Placebo-Controlled Trials.
Flohr C, Weidinger S. Flohr C, et al. J Invest Dermatol. 2017 Jun;137(6):1366-1367. doi: 10.1016/j.jid.2017.02.965. Epub 2017 Feb 28. J Invest Dermatol. 2017. PMID: 28257792 Free article. No abstract available.
The International TREatment of ATopic Eczema (TREAT) Registry Taskforce: An Initiative to Harmonize Data Collection across National Atopic Eczema Photo- and Systemic Therapy Registries.
Spuls PI, Gerbens LAA, Apfelbacher CJ, Wall D, Arents BWM, Barbarot S, Roberts A, Deleuran M, Middelkamp-Hup MA, Vestergaard C, Weidinger S, Schmitt J, Irvine AD, Flohr C. Spuls PI, et al. Among authors: flohr c. J Invest Dermatol. 2017 Sep;137(9):2014-2016. doi: 10.1016/j.jid.2017.05.014. Epub 2017 May 27. J Invest Dermatol. 2017. PMID: 28558913 Free article. No abstract available.
277 results